Blood Glucose Monitoring Devices Market To Reach $30.18 Billion By 2033

Blood Glucose Monitoring Devices Market Growth & Trends

The global blood glucose monitoring devices market size is expected to reach USD 30.18 billion by 2033, registering a CAGR of 8.8% from 2026 to 2033, according to a new report by Grand View Research, Inc. Patients with diabetes and their healthcare professionals benefit significantly from Blood Glucose Monitoring Devices (BGMD). BGMD is becoming more widely accepted as an important component of intensive diabetic treatment. It allows diabetic patients to measure their blood sugar levels within minutes with ease and convenience wherever they are. The continuous glucose monitoring (CGM) devices help analyze the blood glucose level continuously and in real-time. It also helps patients determine the level of dietary intake and dosage of insulin. In addition, factors such as sedentary lifestyles including consumption of junk food, alcohol, and smoking, and a surge in the need for safer and faster diagnoses are expected to boost the market growth during the forecast period.

According to the International Diabetes Federation (IDF), the total number of diabetic patients is expected to expand to 643 million (11.3 %) by 2030 and 783 million (12.2 %) by 2045. Obesity is one of the major factors propelling the prevalence of diabetes. Obese individuals are up to 80 times more likely than non-obese persons to develop diabetes. Studies suggest that 650 million people over the age of 18 are obese. Further, due to the ongoing efforts by the government and healthcare organizations such as the International Diabetes Federation (IDF) to control diabetes, the market is likely to rise at a rapid pace throughout the forecast period. Through a network of stakeholders and collaborators, these organizations provide needed expertise and support diabetes awareness campaigns. Rising health-care funding is also expected to boost market growth.

 Request a free sample copy or view the report summary: Blood Glucose Monitoring Devices Market Report

Blood Glucose Monitoring Devices Market Report Highlights

• The self-monitoring blood glucose devices segment led the market and accounted for a share of 66.0% in 2025, due to its affordability and user-friendly nature. Self-monitoring of blood glucose (SMBG) plays a crucial role in daily diabetes management using a glucose meter to measure blood sugar levels.

• The Bluetooth-enabled devices segment dominated the blood glucose monitoring devices market with a revenue share of 50.2% in 2025. This can be attributed to the increased accuracy of these devices in tracking glucose levels, reduced manual entry errors, and enhanced patient engagement through user-friendly interfaces.

• The hospital segment led the market in 2025 and accounted for a share of 41.1% of the global revenue. The rising cases of hospitalization of diabetic patients and increased hospital expenditures have led to increased adoption of BGM devices as they provide practitioners with instantaneous, reliable data and enhance patients' quality of life by providing accurate treatment plans.

• North America blood glucose monitoring systems market accounted for a share of 38.0% in 2025. The region boasts a large pool of target population with a high prevalence of diabetes, driving the demand for innovative and technologically advanced blood glucose monitoring devices.

Blood Glucose Monitoring Devices Market Segmentation

Grand View Research has segmented the blood glucose monitoring devices market on the basis of product, connectivity, end use, and region:

Blood Glucose Monitoring Devices Product Outlook (Revenue, USD Million, 2021 - 2033)

• Self-Monitoring Devices

  • Blood Glucose Meters

    • Traditional BGMs

    • Smart BGMs

  • Testing Strips

  • Lancets

• Continuous Glucose Monitoring (CGM) Devices

  • Sensors

  • Transmitter and Receiver

  • Insulin Pumps

    • Traditional Insulin Pumps

    • Smart Insulin Pumps

Blood Glucose Monitoring Devices Connectivity Outlook (Revenue, USD Million, 2021 - 2033)

• Bluetooth-Enabled Devices

• Wi-Fi-Enabled Devices

• Near Field Communication (NFC) Devices

• USB Connectivity Devices

Blood Glucose Monitoring Devices End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Hospitals

• Home Care

• Diagnostic Centers

Blood Glucose Monitoring Devices Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

  • Mexico

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Blood Glucose Monitoring Devices Market

• Abbott Laboratories

• Senseonics Holdings, Inc.

• GlucoRx Limited

• Zhejiang POCTech Co., Ltd

• i-SENS, Inc.

• Nemaura Medical Inc.

• Sinocare, Inc.

• Bionime

• AgaMatrix

• Medtronic plc

• F. Hoffmann-La Roche Ltd

• Dexcom, Inc.

• Sanofi

• Novo Nordisk

• Insulet Corporation

• Ypsomed Holdings

• Glysens Incorporated